Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in newly diagnosed glioblastoma
NCT00014170Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2001
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in glioblastoma (GBM), sponsored by National Cancer Institute. Started Mar 2001; status: completed.
02
Drugs
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00014170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014170.